About AD Initiative
Atopic Dermatitis : Where Are We?
Atopic dermatitis (AD), also known as eczema, is one of the most common inflammatory skin disorders worldwide, with an increasing incidence in the past few decades. In recent years, research on the pathophysiology of AD has highlighted the role of skin barrier dysfunction, cutaneous and systemic immune abnormalities, and the role of the microbiome in the development of this condition. An understanding of the underlying causes of AD has led to the development of new targeted therapies and improved methods of treatment for this challenging and chronic disease.
Our Atopic Dermatitis THRIVE program is an online CME tool that aims to provide clinicians with new strategies to improve standards of care for patients with AD. Click on the links above to learn more about best practices for the diagnosis and assessment of AD, clinical profiles of biologic agents for AD, and how to select treatment options.
Atopic Dermatitis THRIVE: Cutting-Edge CME
Our Atopic Dermatitis THRIVE program is an online CME tool that aims to provide clinicians with new strategies to improve standards of care for AD. Our goals are multi-fold:
- Describe pathophysiological findings that have informed the selection of new therapeutic targets.
- Identify best practices for assessment and diagnosis of AD in adults, accounting for biomarkers, phenotype/genotype, comorbidities, and disease burden.
- Review the clinical profiles and mechanisms of action of emerging biologic agents for AD treatment.
- Explain how comorbidities and adherence barriers play a role in treatment choice.
- Discuss patient-centered health care management teams and the respective roles of team members.
Thank you for visiting us today. We welcome you to our website and invite you to explore the links above for cutting-edge clinician- and patient-related information on AD.
Enjoy!
Atopic Dermatitis THRIVE
The Atopic Dermatitis THRIVE initiative includes online CME offerings for clinicians and patients. It is particularly relevant to patient care since we are hoping to empower learners with usable therapeutic strategies to improve clinical experiences with atopic dermatitis.
Through participating in our online offerings and exploring the information on our smart device app, we aim for our participants to more effectively manage patients with AD, ensure their quality of life, and promote a faster return to normalcy in their everyday lives.
About Med Learning Group
The goal of Med Learning Group – an accredited CME provider – is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient.
Med Learning Group has developed strong relationships with several medical associations, community and academic hospitals, patient advocacy groups, managed care organizations, and government agencies. Through these relationships, Med Learning Group has been able to offer validated educational courses created directly for specialty audiences.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive, and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.
